Clovis Oncology
Why Robinhood?
You can watch CLVSQ and buy or sell other stocks, ETFs, and their options commission-free!About CLVSQ
Clovis Oncology, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of innovative anti-cancer agents in the United States, Europe, and additional international markets. Its U.S. marketed product, Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase (PARP), is approved for use in the maintenance treatment and treatment of eligible adult patients with recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer, and also for the treatment of adult patients with a deleterious BRCA mutation (germline and/or somatic)-associated metastatic castration-resistant prostate cancer (mCRPC), which have been treated with androgen receptor-directed therapy and a taxane-based chemotherapy.
CLVSQ Key Statistics
Stock Snapshot
Clovis Oncology(CLVSQ) stock is priced at $0.02, giving the company a market capitalization of 2.17M. It carries a P/E multiple of -0.01.
Clovis Oncology(CLVSQ) stock opened on 2026-05-16 at —. The price climbed to — and dipped to —.
Clovis Oncology(CLVSQ) shares are trading with a volume of 0, against a daily average of 1.16M.
During the past year, Clovis Oncology(CLVSQ) stock moved between $0.01 at its lowest and $2.87 at its peak.
During the past year, Clovis Oncology(CLVSQ) stock moved between $0.01 at its lowest and $2.87 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.